3 hours agoAstraZeneca applies for EU vaccine authorization
Periskopi(5 years ago)
(5 years ago)AstraZeneca applied to the European Union for authorisation of anti vaccine - COVIDD-19, which this British pharmaceutical company has developed in cooperation with Oxford University. The European Bars Agency (EMA) said on Tuesday that the opinion on conditional authorization of the vaccine could issue until January 29th. If approved by EMA and approved officially by [...]
AstraZeneca applied to the European Union for authorisation of anti vaccine - COVIDD-19, which this British pharmaceutical company has developed in cooperation with Oxford University.
The European Bars Agency (EMA) said on Tuesday that the opinion on conditional authorization of the vaccine could issue until January 29th.
If approved by the EMA and approved officially by the European Commission, it will become the third vaccine against COVID-19 disease, which will be available in EU countries.
The two vaccines already approved are Pfizer/ B NTech and Modernna.
European Commission President Ursula von der Leyen said AstraZeneca's application is a “good news”.
“Once the vaccine gets a positive scientific opinion, we will work at full speed to authorize its use in Europe”, von der Leyen wrote on Twitter.
The Oxford/AstraZeneca vaccine has already been approved in several countries, including Argentina, Britain and India.
This vaccine is cheaper to produce and easier to preserve and transport than other vaccines.
Pfizer. BioNTech, for example, must be kept at extremely low temperatures: -70 degrees Celsius.
